TWST

#1255
Twist Bioscience Corporation - Common Stock
66.8 7 USD
-3.13%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
66.87
66.87
Range Annuel
23.30
69.20
Changement quotidien
-3.13%
Changement Mensuel
+16.30%
Evolution sur 6 mois
+114.05%
Changement Annuel
+133.73%
Clôture Précédente
69.0 3
Open
66.8 7
Low
66.8 7
High
66.8 7
Volume
165
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur 202020212022202320242025 TTM

Twist Bioscience Corporation - Common Stock

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.

Nouvelles